Literature DB >> 26948423

TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.

Rana Al-Sadi1, Shuhong Guo1, Dongmei Ye1, Manmeet Rawat1, Thomas Y Ma2.   

Abstract

Tumor necrosis factor (TNF)-α, a key mediator of intestinal inflammation, causes an increase in intestinal epithelial tight junction (TJ) permeability by activating myosin light chain kinase (MLCK; official name MYLK3) gene. However, the precise signaling cascades that mediate the TNF-α-induced activation of MLCK gene and increase in TJ permeability remain unclear. Our aims were to delineate the upstream signaling mechanisms that regulate the TNF-α modulation of intestinal TJ barrier function with the use of in vitro and in vivo intestinal epithelial model systems. TNF-α caused a rapid activation of both canonical and noncanonical NF-κB pathway. NF-κB-inducing kinase (NIK) and mitogen-activated protein kinase kinase-1 (MEKK-1) were activated in response to TNF-α. NIK mediated the TNF-α activation of inhibitory κB kinase (IKK)-α, and MEKK1 mediated the activation of IKK complex, including IKK-β. NIK/IKK-α axis regulated the activation of both NF-κB p50/p65 and RelB/p52 pathways. Surprisingly, the siRNA induced knockdown of NIK, but not MEKK-1, prevented the TNF-α activation of both NF-κB p50/p65 and RelB/p52 and the increase in intestinal TJ permeability. Moreover, NIK/IKK-α/NF-κB p50/p65 axis mediated the TNF-α-induced MLCK gene activation and the subsequent MLCK increase in intestinal TJ permeability. In conclusion, our data show that NIK/IKK-α/regulates the activation of NF-κB p50/p65 and plays an integral role in the TNF-α-induced activation of MLCK gene and increase in intestinal TJ permeability. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26948423      PMCID: PMC4861759          DOI: 10.1016/j.ajpath.2015.12.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  85 in total

1.  Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.

Authors:  Rana Al-Sadi; Shuhong Guo; Karol Dokladny; Matthew A Smith; Dongmei Ye; Archana Kaza; D Martin Watterson; Thomas Y Ma
Journal:  J Interferon Cytokine Res       Date:  2012-07-20       Impact factor: 2.607

Review 2.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

3.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

Review 4.  Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation.

Authors:  Hongxiu Li; Xin Lin
Journal:  Cytokine       Date:  2008-01       Impact factor: 3.861

Review 5.  Clinical perspectives in Crohn's disease. Moving forward with anti-TNF-alpha therapy: current needs and future treatments.

Authors:  William J Sandborn
Journal:  Rev Gastroenterol Disord       Date:  2007

6.  Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.

Authors:  Prashant B Shambharkar; Marzenna Blonska; Bhanu P Pappu; Hongxiu Li; Yun You; Hiroaki Sakurai; Bryant G Darnay; Hiromitsu Hara; Josef Penninger; Xin Lin
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

7.  The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Authors:  B M Paterson; K M Lammers; M C Arrieta; A Fasano; J B Meddings
Journal:  Aliment Pharmacol Ther       Date:  2007-09-01       Impact factor: 8.171

8.  Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability.

Authors:  Rana Al-Sadi; Dongmei Ye; Karol Dokladny; Thomas Y Ma
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 9.  Role of disorder in IκB-NFκB interaction.

Authors:  H Jane Dyson; Elizabeth A Komives
Journal:  IUBMB Life       Date:  2012-05-09       Impact factor: 3.885

Review 10.  Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).

Authors:  Lotte Dinesen; Simon Travis
Journal:  Int J Nanomedicine       Date:  2007
View more
  39 in total

Review 1.  Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation.

Authors:  Lediya Cheru; Charles F Saylor; Janet Lo
Journal:  Curr Obes Rep       Date:  2019-06

2.  Lipopolysaccharide-Induced Increase in Intestinal Permeability Is Mediated by TAK-1 Activation of IKK and MLCK/MYLK Gene.

Authors:  Meghali Nighot; Manmeet Rawat; Rana Al-Sadi; Eliseo F Castillo; Prashant Nighot; Thomas Y Ma
Journal:  Am J Pathol       Date:  2019-02-01       Impact factor: 4.307

3.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

4.  Nano NiO induced liver toxicity via activating the NF-κB signaling pathway in rats.

Authors:  Fangfang Liu; Xuhong Chang; Minmin Tian; An Zhu; Lingyue Zou; Aijie Han; Li Su; Sheng Li; Yingbiao Sun
Journal:  Toxicol Res (Camb)       Date:  2017-02-08       Impact factor: 3.524

Review 5.  Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xin Fang
Journal:  Metab Brain Dis       Date:  2018-04-22       Impact factor: 3.584

6.  Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation.

Authors:  Aditya Garg; Angela Zhao; Sarah L Erickson; Subhajit Mukherjee; Aik Jiang Lau; Laurie Alston; Thomas K H Chang; Sridhar Mani; Simon A Hirota
Journal:  J Pharmacol Exp Ther       Date:  2016-07-20       Impact factor: 4.030

Review 7.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

8.  Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide.

Authors:  M Antón; A Rodríguez-González; A Ballesta; N González; A Del Pozo; F R de Fonseca; M L Gómez-Lus; J C Leza; B García-Bueno; J R Caso; L Orio
Journal:  Br J Pharmacol       Date:  2018-10-29       Impact factor: 8.739

9.  The effect of probiotic supplementation on performance, inflammatory markers and gastro-intestinal symptoms in elite road cyclists.

Authors:  Chen Schreiber; Snait Tamir; Ron Golan; Ayelet Weinstein; Yitzhak Weinstein
Journal:  J Int Soc Sports Nutr       Date:  2021-05-17       Impact factor: 5.150

10.  m6A mRNA Methylation Regulates Epithelial Innate Antimicrobial Defense Against Cryptosporidial Infection.

Authors:  Zijie Xia; Jihao Xu; Eugene Lu; Wei He; Silu Deng; Ai-Yu Gong; Juliane Strass-Soukup; Gislaine A Martins; Guoqing Lu; Xian-Ming Chen
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.